Wooseong Kim
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Microbiology top 1%
- Antimicrobial Peptides and Activities
Papers in
-
- Bacterial biofilms and quorum sensing 19
- Microbial Metabolic Engineering and Bioproduction 11
-
- Antimicrobial Resistance in Staphylococcus 23
- Co-authors
- Eleftherios Mylonakis (26 shared papers)Yunjin Jung (30 shared papers)Beth Burgwyn Fuchs (16 shared papers)Frederick M. Ausubel (12 shared papers)Annie L. Conery (7 shared papers)Rajmohan Rajamuthiah (7 shared papers)Seongkeun Jeong (22 shared papers)Jin‐Wook Yoo (16 shared papers)
- Journals
- Future Medicinal Chemistry (6 papers)Drug Design Development and Therapy (5 papers)Antibiotics (5 papers)PLoS ONE (4 papers)European Journal of Pharmacology (3 papers)
- Partner nations
- South KoreaUnited StatesSingapore
In The Last Decade
Wooseong Kim
96 papers receiving 2.6k citations
Wooseong Kim's Hit Papers
Peers
Comparison fields: 5 of 135
- Molecular Medicine 264
- Microbiology 288
- Aging 59
- Pharmaceutical Science 138
- Infectious Diseases 313
Countries citing papers authored by Wooseong Kim
This map shows the geographic impact of Wooseong Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wooseong Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wooseong Kim more than expected).
Fields of papers citing papers by Wooseong Kim
This network shows the impact of papers produced by Wooseong Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wooseong Kim. The network helps show where Wooseong Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Wooseong Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A new class of synthetic retinoid antibiotics effective against bacterial persisters Hit paper breakdown → | 2018 | 319 |
| 2 | 2020 | 200 | |
| 3 | 2013 | 136 | |
| 4 | 2015 | 118 | |
| 5 | 2018 | 72 | |
| 6 | 2017 | 62 | |
| 7 | 2018 | 62 | |
| 8 | 2014 | 59 | |
| 9 | 2015 | 58 | |
| 10 | 2013 | 54 | |
| 11 | 2017 | 53 | |
| 12 | 2013 | 49 | |
| 13 | 2008 | 49 | |
| 14 | 2017 | 48 | |
| 15 | 2018 | 48 | |
| 16 | 2020 | 48 | |
| 17 | 2020 | 45 | |
| 18 | 2020 | 44 | |
| 19 | 2017 | 37 | |
| 20 | 2016 | 37 |
About Wooseong Kim
Wooseong Kim is a scholar working on Molecular Biology, Infectious Diseases, Pharmacology, Microbiology and Cancer Research, having authored 98 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (23 papers), Bacterial biofilms and quorum sensing (19 papers), Antimicrobial Peptides and Activities (14 papers), Microbial Metabolic Engineering and Bioproduction (11 papers), Helicobacter pylori-related gastroenterology studies (7 papers), Microbial Natural Products and Biosynthesis (7 papers), Inflammatory Bowel Disease (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Molecular Medicine (264 citations), Microbiology (288 citations), Aging (59 citations), Pharmaceutical Science (138 citations) and Infectious Diseases (313 citations). Wooseong Kim has collaborated with scholars based in South Korea, United States and Singapore. Frequent co-authors include Eleftherios Mylonakis, Yunjin Jung, Beth Burgwyn Fuchs, Frederick M. Ausubel, Annie L. Conery, Rajmohan Rajamuthiah, Seongkeun Jeong, Jin‐Wook Yoo, Yung-Hun Yang and Shashi Kant Bhatia. Their work appears in journals such as Future Medicinal Chemistry, Drug Design Development and Therapy, Antibiotics, PLoS ONE and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.